Open Menu icon
JOIN
SEARCH
Home
Press Releases

Biosimilars Council Press Releases

Press Releases
  • Press Releases

Study Finds Middlemen Increasingly Block Patient Access to New Generics
  • Press Releases

AAM Statement on the Consolidated Appropriations Act of 2023
  • Press Releases

AAM Statement on CMS’s Proposed Rule Requiring Generic Drugs to be Covered on Generic Tiers
  • Press Releases

Raising Awareness for Biosimilars for Stakeholders Around the World
  • Press Releases

AAM Statement on President Biden’s Executive Order on Lowering Prescription Drug Costs
  • Press Releases

Generic and Biosimilar Drugs Generate A Record $373 Billion For America’s Patients and Healthcare System in 2021
  • Press Releases

AAM Statement on the Centers for Medicare & Medicaid Services’ Implementation of Medicare Part B Payment Changes for Biosimilars
  • Press Releases

AAM Statement: New Study Shows Formulary Abuses Force Patients to Pay More for Generic Drugs Even as the Prices of Those Drugs Go Down
  • Press Releases

AAM Statement on Senate Passage of Inflation Reduction Act
  • Press Releases

Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs
  • Press Releases

AAM Statement on BBB 2.0
  • Press Releases

AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
Load More
JOIN
SEARCH